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Abstract
Introduction
Brugada syndrome is a sodium channel deficiency in the 
myocardium that can cause ECG changes and sudden cardiac 
death.  The myocardium deficient sodium channels can be 
inherited or affected by environment factors such as fever or 
medications.  Screening for this syndrome can be challenging 
because many times the first symptom of Brugada syndrome is 
cardiac arrest.  Though incidents of sudden cardiac deaths are low, 
sudden cardiac death can impact families and communities.  
Preventing sudden cardiac death in these patients through sensible, 
reasonable preventive practices is the goal. 
Research Question
Literature Review




• Patients diagnosed with Brugada syndrome have a low relative 
risk of sudden cardiac death when that is the single criteria.  
When syncope is added with type 1 ECG changes that risk 
increases.  
• Our screening practices of asking about family history stands to 
be an ineffective tool.  A meta-analysis review of 27 studies 
looking at cardiac events in patients with suspected Brugada
syndrome was performed.  
• One area that helped identify risk was subjects that had Brugada
syndrome and had either an aborted cardiac arrest or syncope 
were at 4.97 fold increase risk of sudden cardiac death.  Those 
subjects that had Brugada syndrome with type 1 ECG changes 
had 2.78 fold increase risk of sudden cardiac death (Wu, 2016).  
An area that did not show significance was family history of the 
disease, genetic mutation, or being male. 
• Standard ECG screening has been performed in other countries.  
In Italy, screening ECG’s is claimed to have reduced sudden 
cardiac events by 85% (Maron,2014). Performing ECG 
screening has been met by some resistance in the United States. 
• Another interesting note was that most providers in another 
survey also did not cover all the American Heart Association 
recommended 12 points of physical exam and medical history 
(Patel,2016). 
• The European Society of Cardiology and the International 
Olympic Committee recommend ECG screening for athletes.  
The screening is viewed to be justifiable from an ethical, legal, 
and medical bases.  There should be another step to not just 
limit ECG screening to athletes.
• Does physical exam and personal medical history provide an 
accurate risk assessment to prevent sudden cardiac death in 
Brugada syndrome compared to using electrocardiogram alone?  
Is routine ECG cost effective?
Performing a 12 lead ECG is fairly inexpensive.  It is anticipated 
that performing 12 lead ECG’s more routinely and pairing it 
with medical history and physical exam can aid in helping 
diagnosis Brugada syndrome.  The diagnosis of Brugada 
Syndrome can help a provider with patient education.   There are 
risk stratification tools, however they require further research.  
Those with the syndrome can be given education in regards to 
further evaluation and treatment. That education is geared 
towards helping the patient understand their risk and how steps 
such as CPR and AED education can improve survivability 
should they experience a cardiac arrest event.
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Statement of the Problem
Brugada syndrome’s worse and sometimes only symptom is 
sudden cardiac arrest.  Cardiac arrest is often deadly and for those 
that survive can have lifelong disabilities.  Incidents of events are 
low, however, one event can have a profound impact on families 
and communities.  The goal is to find screening tools and 
techniques that can help determine an individual’s risk.  
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Table 2    Patients’ characteristics according to LTA events during follow-up and predictive factors for LTA in univariate analysis (N ¼ 106) 
 
 
Characteristic LTA event (n ¼ 10) No LTA event (n ¼ 96) HR (95% CI) P 
Sex: male 6 (60) 52 (54) 0.79 (0.22–2.81) .72 
Age at diagnosis (y) 6.5 ± 7.0 11.6 ± 5.4 0.86 (0.76–0.96) .009 
Age at diagnosis o15 y 7 (70) 60 (62) 0.74 (0.19–2.89) .66 
Follow-up duration (mo) 42 (6–73) 55 (15–103) — — 
Symptoms at diagnosis 7 (70) 14 (15) 9.65 (2.481–37.49) .001 
Spontaneous type 1 ECG pattern 8 (80) 28 (29) 9.1 (1.9–42.96) .005 
Family history of SCD 3 (30) 43 (45) 2.12 (0.55–8.21) .28 
ICD 5 (50) 17 (18) 3.85 (1.11–13.36) .003 
SCN5A mutations 9 (90) 49 (51) — .08* 
Values are presented as mean ± SD, as median (1st–3rd quartile), as n (%), or as otherwise indicated. 
CI ¼ confidence interval; ECG ¼ electrocardiographic; HR ¼ hazard ratio; ICD ¼ implantable cardioverter-defibrillator; LTA ¼ life-threatening arrhythmias; 
SCD ¼ sudden cardiac death. 
*P value calculated using the log-rank test. 
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• It is estimated that four percent of all sudden cardiac deaths are 
related to Brugada syndrome with 20% of those sudden cardiac 
deaths having no structural heart abnormalities 
(Okamura,2015). 
• There seems to be a male and Asian decent dominance.  
Dynamed (Dynamed, 2016) has a reported prevalence in Asia is 
about 1 per 1000 people. Prevalence of Brugada syndrome 
(BrS) in the general population is estimated to be 5/10,000 
people and may be lower in Europe and the United States.
• Clinical history of familial sudden cardiac arrest has 
traditionally been used to identify risk in patients.  Studies 
suggest that family history alone in those that have Brugada 
syndrome is not a reliable predictor of sudden cardiac arrest 
(Rivard,2016).  
• Increased risk of sudden cardiac arrest can be associated with a 
group of symptoms.  They are type 1 ECG changes associated 
with syncope and reproducible upon electrophysiology studies.  
This mostly affects the male gender and younger than 45 years 
of age.  
• Brugada syndrome is a sodium channel deficiency in the 
myocardium that can cause arrhythmias and sudden 
cardiac death.  The myocardium deficient sodium channels 
can be inherited or affected by environment factors such 
as fever or medications.  
• Screening for this syndrome can be challenging because 
many times the first symptom of Brugada syndrome is 
cardiac arrest.  Though incidents of sudden cardiac deaths 
are low, sudden cardiac death can impact families and 
communities.  
• In Italy, screening ECG’s is claimed to have reduced 
sudden cardiac events by 85% (Maron, 2014).  Preventing 
sudden cardiac death in these patients through sensible, 
reasonable preventive practices such as screening 
electrocardiograms and patient education is the goal.  
• Performing 12 lead electrocardiograms (ECGs) in a 
screening nature and pairing it with medical history and 
physical exam can help increase discovery of Brugada 
syndrome and decrease associated cardiac events.  
• The American Heart Association and the American 
College of Cardiology currently do not recommend 
screening ECGs.  The International Olympic Committee 
and the European Society of Cardiology recommend 
screening ECGs for athletes.  
• The search was limited to articles that were published 
within the last 10 years.  Databases searched included 
Pubmed, CINAHL, and SPORTDiscus.  Several articles 
were found to be of significance to the topic.  
• Key terms: Brugada syndrome, sudden cardiac death, risk 
stratification, and type 1 ECG changes
